The COVID-19 post-apocalyptic laboratory
The COVID-19 post-apocalyptic laboratory
批准号:
570902-2021
负责人:
Organ, MichaelMG
金额:
$19.67万
依托单位:
依托单位国家:
加拿大
项目类别:
Alliance Grants
财政年份:
2022
资助国家:
加拿大
项目状态:
已结题
起止时间:
2022-01-01 至 2023-12-31
中文摘要
点击翻译按钮获取中文摘要
英文摘要
The current COVID-19 pandemic has exposed Canada's glaring inability to effectively supply its population with essential compounds for medical applications. Canada's incapacity to prepare a SARS-CoV-2 vaccine and anti-bacterials to treat the resultant lung superinfections, have left all Canadians vulnerable and our economy languishing. According to Drug Shortages Canada, there 15 critical shortages or discontinuations of essential medications in Canada; this is unacceptable for a G8 nation and threatens our security. Conventional synthesis of drug molecules uses technologies that are vast in scale employing large batch reactors that require tens to hundreds of millions of dollars in capital investments. Further, the failure of an advanced-stage synthetic batch for a critical drug can cause an operating loss of hundreds of thousands to millions of dollars. It is hard for Canadian business to build a case to take on such risks given the comparatively small market in Canada. An alternative strategy is to synthesize these precious compounds in flow reactors where smaller amounts of material are made at any single point in time, but continuously over longer periods of time and/or in parallel. This dramatically reduces capital investment, while making processes more manageable, safer, and eliminating costly batch failures. COVID-19 turned the spotlight on worker safety and dramatically altered the way that chemical companies operate by forcing them into shiftwork and other strategies to lower the density of workers on site. Flow chemistry technology, coupled with artificial intelligence (AI) and internet of things (IoT) will enable reactions to be set up, monitored, and tweaked remotely using robotically-fed custom-designed flow reactors being developed by the Team. These results will shared widely across Canadian industry and nuclear-medicine departments in hospitals through the involvement of Worker Safety and Prevention Services (WSPS), which will dramatically improve worker safety and would have the additional benefit of offering primary care-caregivers of children, the elderly and the seriously ill an opportunity to work in these rewarding areas by being able to conduct their work remotely.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Nominated for the NSERC John C. Polanyi award
-
批准号:507882-2018
-
项目类别:John C. Polanyi Award
-
资助金额:$3.64万
-
财政年份:2022
-
负责人:Organ, MichaelMG
-
依托单位:
国内基金
海外基金
登录
查看更多内容
芽孢杆菌TR19-1对魔芋腐皮镰刀菌拮抗机理研究
-
批准号:JCZRLH202601657
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
1H/19F多核MRI术中可视化免疫抑制巨噬细胞定位脑胶质瘤浸润边界
-
批准号:JCZRMS202602505
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
ATPIF1调节线粒体膜电位影响靶向CD19 CAR-T细胞抗肿瘤活性的作用及机制
-
批准号:2026JJ80001
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:钟根深
-
依托单位:
CD19/BCMA双靶向CAR-NK细胞治疗难治性SLE:作用机制与临床前转化研究
-
批准号:2026JJ81339
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:谢希
-
依托单位:
运动通过m6A修饰上调miR-19b-3p改善阿尔茨海默病Aβ代谢 的机制研究
-
批准号:JCZRLH202601558
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
水稻转录因子OsDi19-3抗逆功能研究
-
批准号:JCZRLH202600842
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
tRF-19-BZOS4YE2调控FN1/TGF-β轴促进结直肠癌侵袭转移的机制及干预研究
-
批准号:JCZRQNB202601040
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
多鳞白甲鱼高效繁育技术体系研发
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
lncRNA H19通过介导Ras/ULK1信号影响乳腺癌细胞线粒体稳态及糖酵解的作用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:施文标
-
依托单位:
老年认知障碍者与主要照护者的沟通现状及影响因素的混合性研究
-
批准号:GDHLYJYQ202410
-
项目类别:省市级项目
-
资助金额:0.3万元
-
批准年份:2025
-
负责人:贾佳欣
-
依托单位: